Ozempic 0.25-0.5 MG/dose pen 3ML
Ended Awarded
- Contract number
- SPE2DB25FR3JG
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $36,184
Award facts
- Contract value 100% obligated
- $36,183.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Ozempic 0.25-0.5 mg/dose pens (3 mL) with a ceiling value of $36,183.62. This firm fixed-price delivery order, with an ultimate completion date of September 16, 2025, was awarded without a set-aside designation through competitive procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a substantial federal contract portfolio focused on supplying pharmaceutical products and medical supplies to the Defense Logistics Agency and other federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The company's federal awards demonstrate consistent capability in delivering a broad range of medications across multiple therapeutic domains, including diabetes treatments, neurological medications, pain management drugs, and specialized medical supplies. The award of this Ozempic delivery order reflects AmerisourceBergen's ongoing role as a critical vendor within the DLA's medical supply chain infrastructure for supporting military and veteran healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FR3JG?
SPE2DB25FR3JG was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 15, 2025.
How much is contract SPE2DB25FR3JG worth?
The government has obligated $36,184 on SPE2DB25FR3JG.
Is contract SPE2DB25FR3JG an order under another contract?
Yes. SPE2DB25FR3JG is a delivery order under SPE2DB22D2218, an indefinite delivery contract.
Was contract SPE2DB25FR3JG competed?
The extent of competition for SPE2DB25FR3JG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award